浏览全部资源
扫码关注微信
1.山东中医药大学药学院,济南 250355
2.山东宏济堂制药集团股份有限公司,济南 250109
3.山东中医药大学青岛中医药科学院,山东 青岛 266112
Published:15 November 2022,
Received:06 June 2022,
Revised:10 October 2022,
扫 描 看 全 文
赵方舒,张爱均,刘苗苗等.金贝口服液抗小鼠甲型H1N1流感病毒及继发性肺炎链球菌感染作用研究 Δ[J].中国药房,2022,33(21):2622-2626.
ZHAO Fangshu,ZHANG Aijun,LIU Miaomiao,et al.Study on the effects of Jinbei oral liquid against influenza A H1N1 virus and secondary Streptococcus pneumoniae infection of mice[J].ZHONGGUO YAOFANG,2022,33(21):2622-2626.
赵方舒,张爱均,刘苗苗等.金贝口服液抗小鼠甲型H1N1流感病毒及继发性肺炎链球菌感染作用研究 Δ[J].中国药房,2022,33(21):2622-2626. DOI: 10.6039/j.issn.1001-0408.2022.21.11.
ZHAO Fangshu,ZHANG Aijun,LIU Miaomiao,et al.Study on the effects of Jinbei oral liquid against influenza A H1N1 virus and secondary Streptococcus pneumoniae infection of mice[J].ZHONGGUO YAOFANG,2022,33(21):2622-2626. DOI: 10.6039/j.issn.1001-0408.2022.21.11.
目的
2
研究金贝口服液体内抗小鼠甲型H1N1流感病毒及继发性肺炎链球菌感染的作用,为其临床应用提供参考。
方法
2
以磷酸奥司他韦胶囊(25.6 mg/kg)为阳性对照进行实验。通过滴鼻含0.8个半数致死量(LD
50
)的H1N1病毒液复制小鼠甲型H1N1流感病毒感染模型,以体质量、肺指数、肺病毒载量、肺组织病理形态变化以及血清中肿瘤坏死因子α(TNF-α)、白细胞介素1β(IL-1β)、IL-6水平为指标,考察15.6、7.8、3.9 mL/kg金贝口服液体内抗甲型H1N1流感病毒的作用。通过滴鼻含0.5个LD
50
的H1N1病毒液和含1×10
9
个菌落形成单位的肺炎链球菌液复制继发性肺炎链球菌感染模型,以小鼠死亡情况、肺指数、鼻腔和肺部细菌载量以及血清中干扰素β(IFN-β)、IL-17、IL-23水平为指标,考察15.6 mL/kg金贝口服液体内抗继发性肺炎链球菌感染的作用。
结果
2
15.6、7.8 mL/kg金贝口服液给药6 d后,均可显著升高甲型H1N1流感病毒感染小鼠异常降低的体质量,显著降低其异常升高的肺指数及血清中TNF-α、IL-1β、IL-6水平(
P
<0.05),显著降低其肺部病毒载量(
P
<0.05),减轻其肺组织病变程度。15.6 mL/kg金贝口服液还可显著延长病毒-细菌共感染小鼠的存活时间(
P
<0.05),降低其死亡率;显著升高其异常降低的体质量和血清中IL-17、IL-23水平(
P
<0.05),显著降低其鼻腔和肺部细菌载量以及血清中异常升高的IFN-β水平(
P
<0.05)。
结论
2
金贝口服液具有一定的抗小鼠甲型H1N1流感病毒感染作用,且能通过恢复17型免疫功能帮助机体抵抗继发性肺炎链球菌感染。
OBJECTIVE
2
To study the effects of Jinbei oral liquid against influenza A H1N1 virus and secondary
Streptococcus pneumoniae
infection of rats, and to provide reference for its clinical application.
METHODS
2
Oseltamivir phosphate capsule (25.6 mg/kg) was used as a positive control. Influenza A H1N1 virus infection model of mice was established by nasal drops of H1N1 virus containing 0.8 median lethal dose (LD
50
). The body mass, lung index, lung viral load, pathological changes of lung tissue, and serum levels of tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β) and IL-6 were used as indexes to investigate the anti-H1N1 virus effect of 15.6, 7.8 and 3.9 mL/kg Jinbei oral liquid
in vivo
. The model of secondary
S. pneumoniae
infection was established by nasal drops of H1N1 virus solution containing 0.5 LD
50
and
S. pneumoniae
solution containing 1×10
9
colony forming units. The death, lung index, nasal and lung bacterial load, serum levels of interferon-β (IFN-β), IL-17 and IL-23 were used as indexes to investigate the effects of 15.6 mL/kg Jinbei oral liquid against secondary
S. pneumoniae
infection.
RESULTS
2
After 6 days of administration, both 15.6 and 7.8 mL/kg Jinbei oral liquid significantly increased the abnormally reduced body weight of influenza A H1N1 virus infected mice, significantly reduced the abnormally increased lung index and serum levels of TNF-α, IL-1β, IL-6 (
P
<0.05); it also significantly reduced the viral load in the lung (
P
<0.05) and alleviated the degree of lung tissue lesions. At the same time, 15.6 mL/kg Jinbei oral liquid significantly prolonged the survival time of mice co-infected with virus and bacteria (
P
<0.05) and reduced the mortality rate; it also significantly increased the abnormally reduced body weight and serum levels of IL-17 and IL-23 (
P
<0.05), while reduced the nasal and lung bacterial loads and the abnormally increased serum level of IFN-β (
P
<0.05).
CONCLUSIONS
2
Jinbei oral liquid has a certain anti-influenza A H1N1 virus infection effect of rats and can help the body resist secondary
S. pneumoniae
infection by restoring the type 17 antibacterial immune function.
金贝口服液甲型H1N1流感病毒肺炎链球菌继发性细菌感染
influenza A H1N1Streptococcus pneumoniaesecondary bacterial infection
IULIANO A D,ROGUSKI K M,CHANG H H,et al. Estimates of global seasonal influenza-associated respiratory mortality:a modelling study[J]. Lancet,2018,391(10127):1285-1300.
勾雪梅. IL-6在流感病毒-肺炎链球菌共感染肺炎及肺炎链球菌肺炎继发脓毒症中的作用及机制研究[D]. 重庆:重庆医科大学,2021.
MACINTYRE C R,CHUGHTAI A A,BARNES M,et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza A(H1N1)pdm09[J]. BMC Infect Dis,2018,18(1):637.
梅周芳,陈家君,施天昀,等. 黄芪甲苷对甲型H1N1流感病毒和呼吸道合胞病毒的抑制作用[J]. 中国动物传染病学报,2017,25(5):5-10.
段琦梅,梁宗锁,杨东风,等.黄芪、党参乙醇提取物抗菌活性研究[J].中成药,2012,34(11):2220-2222.
梁羽茜,王如峰,黄松丽,等. 黄芪水煎剂对流感病毒感染Raw264.7细胞的保护作用及机制[J]. 中国药理学通报,2022,38(4):639-640.
GENG Z K,LI Y Q,CUI Q H,et al. Exploration of the mechanisms of Ge Gen Decoction against influenza A virus infection[J]. Chin J Nat Med,2019,17(9):650-662.
RYU S,COWLING B J. Human influenza epidemiology[J]. Cold Spring Harb Perspect Med,2021,11(12):a038356.
PARK S S,GONZALEZ-JUARBE N,RIEGLER A N,et al. Streptococcus pneumoniae binds to host GAPDH on dying lung epithelial cells worsening secondary infection following influenza[J]. Cell Rep,2021,35(11):109267.
GAO G H,LAW F,WONG R N S,et al. A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans[J]. ADMET DMPK,2019,7(1):22-43.
ROBINSON K M,MCHUGH K J,MANDALAPU S,et al. Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production[J]. J Infect Dis,2014,209(6):865-875.
KUDVA A,SCHELLER E V,ROBINSON K M,et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice[J]. J Immunol,2011,186(3):1666-1674.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution